{"success":true,"data":{"pressRelease":{"id":"131702","rtpr_id":"nACS2ggwha","ticker":"GLGH","exchange":"","all_tickers":["GLGH"],"title":"GLG Life Tech Corporation Reports 2026 Second Quarter Financial Results","author":"ACCESSWIRE","published_at":"2026-08-31T23:39:51.614Z","article_body":"VANCOUVER, BC / ACCESS Newswire (https://www.accessnewswire.com/) / August 31,\n2026 / GLG Life Tech Corporation (NEX:GLG.H) (\"GLG\" or the \"Company\"), a\nglobal leader in the agricultural and commercial development of high-quality\nzero-calorie natural sweeteners, announces financial results for the three and\nsix months ended June 30, 2026. The complete set of financial statements and\nmanagement discussion and analysis are available on SEDAR and on the Company's\nwebsite at www.glglifetech.com.\n\nFINANCIAL SUMMARY\n\nThe Company reported revenues of $2.3 million in the second quarter of 2026, a\ndecrease of 19% compared with $2.9 million in revenues for the second quarter\nof 2025. The Company reported gross profit for continuing operations of $0.5\nmillion for the three months ended June 30, 2026, compared to $0.4 million in\ngross profit for the same period last year. The gross profit margin was 22%\nfor the three months ended June 30, 2026, compared to 15% for the same period\nin 2025, or an increase of seven percentage points.\n\nFor the six months ended June 30, 2026, the Company reported revenues of $4.7\nmillion, a decrease of 23% compared with $6.0 million in revenues for the\ncomparable period in 2025. The Company reported gross profit for continuing\noperations of $0.8 million for the six months ended June 30, 2026, compared to\n$0.9 million in gross profit for the same period last year. The gross profit\nmargin was 17% for the six months ended June 30, 2026, compared to 15% for the\nsame period in 2025, or a decrease of two percentage points.\n\nFor the three months ended June 30, 2026, compared to the same period in 2025,\nSG&A expenses were even at $0.3 million. For the six months ended June 30,\n2026, compared to the same period in 2025, SG&A expenses were even at $0.6\nmillion.\n\nFor the three months ended June 30, 2026, the Company had net loss\nattributable to the Company from continuing operations of $6.1 million, an\nincrease in net loss of $29.9 million over the comparable period in 2025 (net\nincome of $28.2 million), when the Company recorded a substantial one-time\ngain from its disposal of its Runhai subsidiary.\n\nFor the six months ended June 30, 2026, the Company had net loss attributable\nto the Company from continuing operations of $11.6 million, an increase in net\nloss of $32.2 million over the comparable period in 2025 (net income of $20.6\nmillion).\n\nThe Company reported net loss per share from continuing operations of $0.16\nfor the second quarter 2026, a $0.78 increase in net loss per share relative\nto the second quarter of 2025 ($0.62 net income from continuing operations per\nshare). For the first six months of 2026, the Company reported net loss per\nshare from continuing operations of $0.30, an $0.84 increase in net loss per\nshare relative to the comparable period in 2025 ($0.54 net income from\ncontinuing operations per share).\n\nCORPORATE DEVELOPMENTS\n\nThe Company has held its Annual General Meeting of Shareholders on June 30,\n2026, at its Corporate Headquarters in Richmond, B.C. The shareholders voted\nin favor of all five nominated directors, with favorable votes for each\nexceeding 99%. Dr. Luke Zhang continues as Chairman of the Board and Chief\nExecutive Officer and Mr. Brian Palmieri continues as Vice Chairman of the\nBoard. Mr. David Bishop, Madame Liu Yingchun and Mr. Simon Springett continue\nas directors of the Company.\n\nCompany Outlook\n\nIn recent years, management focused particularly on mitigating the losses -\nespecially from a cash or EBITDA perspective - that the Company suffered in\nprior years and to ameliorate the Company's financial position. As a result of\nthose sustained losses, the Company has lacked the cash necessary to fully\nfund the business operations and strategic product initiatives. The Company\ncontinues to manage its cash flows carefully to mitigate risk of insolvency\nand Management's efforts have been successful in improving the Company's\nperformance, particularly its cash flows, with the Company regularly producing\npositive EBITDA. On the other hand, interest charges, most of which continue\nto be accrued rather than paid, continue to have significant impact on the\nCompany's income statement and balance sheet. As a result of these efforts, in\nrecent years and at a present, management has been successful in improving the\nCompany's cash flows compared to prior years. Nevertheless, without an\ninfusion of cash in the months ahead, the Company may not be able to realize\nits strategic plans and could eventually cease to be a going concern.\n\nA factor that has over time contributed to the Company's financial situation\nis the competitive price pressure in the stevia market over the last few years\nthat has reduced mainstream \"Reb A\" products (such as Reb A 80 and Reb A 97)\nto the lowest price levels in years; less mainstream products such as \"Reb M\"\nas well as more specialized products have also more recently been facing\nsimilarly competitive price pressure. Monk fruit prices have also become\nhighly competitive in the marketplace. To maintain margins at sustainable\nlevels, the Company has focused on managing cost of goods sold by working with\nits exclusive supplier, HHY, and continues to strive for a mix of products\nthat is weighted more heavily on higher margin, specialty products, and has\nfocused more on direct sales rather than through distributors. Margins,\nhowever, remain slimmer than desired and the impact of special tariff actions\nremains unclear.\n\nTo address operating cash requirements, management previously negotiated\nrevolving loan facilities with third parties for working capital purposes.\nManagement continues to work with third parties for its working capital needs.\nThis has been a significant departure from the Company's prior practice of\narranging loans with related parties to fund the Company's operations and the\nCompany has been successful in securing and managing these loan facilities.\n\nFurther, with an emphasis on maintaining positive cash flow, the Company has\ntaken decisive steps in the last few years to reduce its SG&A costs as well as\nreduce the cost of goods sold. In that time period, both its North American\noperations and, while extant, its Chinese operations significantly reduced\nSG&A costs. For many years, the Company's production capacity had been far\ngreater than its projected order levels, as it had then sought rapid increases\nin orders for Reb A products. Instead, a few years ago, the Company pivoted to\nfocus on \"right-sizing\" its then-extant Chinese operations - i.e., to optimize\nstaffing and production planning to meet the Company's then-projected\nproduction requirements while retaining the ability to accommodate growth in\nfuture order volumes - and management made significant progress in this area.\nThese efforts, prior to disposing of the Chinese subsidiaries, enabled the\nCompany to sell its goods at more competitive and/or more profitable prices,\nnotwithstanding the competitive price pressures arising in the market. Against\nthis historical backdrop, the Company strives to maintain product cost\nefficiencies through its production arrangement with HHY.\n\nManagement has also availed itself of opportunities to improve the Company's\nbalance sheet - to improve the Company's working capital position and to\nalleviate the debt burden that has impeded the Company's progress for many\nyears now. In 2020, management realized the sale of one of its two idle\nassets; the sale of the \"Runhao\" facility resulted in significant debt\nreduction. In 2023, the Company also realized significant debt reduction\nthrough the bankruptcy liquidation of its other long-idled asset, \"Runyang\".\nShareholders, on May 22, 2025 (and as noted further above), approved the\ntransfer of the Company's Runhai facility on terms similar to the previously\nconsummated transfer of the Company's Runde facility. The Company has thereby\nremoved Chinese bank debt from its books, with only related party debt and\nthird-party working capital loans reflected as debt on its balance sheet. The\nCompany has kept its manufacturing capabilities and practices intact through\nits contract relationship with HHY, comprised of essentially the same\npersonnel and managed under the same strict protocols as was in place with the\nCompany's Runde subsidiary, with manufacturing performed at the same Qingdao\nRunde facility.\n\nWhile revenue trends were increasing from late 2023 into early 2025,\nManagement has more recently observed indications that the growth trend -\npreviously driven both by generally increasing sales volumes from existing\ncustomers and the acquisition of new customers - is at present no longer being\nsustained. It is possible that our customers' purchasing flows are being\nimpacted by concern over global macroeconomic factors and/or in some cases (at\nleast anecdotally) reflecting weakening consumer demand across an array of end\ncustomer products (not limited to products utilizing sweeteners).\nNevertheless, Management continues to focus on ways to grow revenues - whether\nthrough innovative product offerings, new customer acquisition, ensuring\ncustomer retention, and other efforts - as Management remains driven in part,\nas a baseline goal, of ensuring EBITDA / cash flow. Management's efforts over\nthe last two years have been successful in realizing that goal and Management\naims to continue that trend.\n\nAgainst this backdrop, the Company has faced significant regulatory hurdles.\nThe Company had been cease-traded, as a result of its delay in filing its 2023\nfull-year financials (since filed, on June 28, 2024), pursuant to a British\nColumbia Securities Commission order (the failure-to-file cease trade order or\n\"FFCTO\"). As a result of that filing delay, the Company was also delayed in\nfiling its interim first quarter financials for 2024 (filed on July 23, 2024).\nFurther, the Company was under a delisting review initiated by the TSX, on the\nbasis of the Company's share price and market capitalization remaining lower\nthan the TSX's requirements, as well as the Company's sustained losses over\nthe years and negative working capital situation, that as noted above,\nculminated in a decision by the TSX to delist the Company's shares effective\nclose of business September 3, 2024.\n\nThe Company has since transferred its listing to the NEX exchange, where it is\ncurrently listed (as of September 4, 2024). While the FFCTO had been in effect\nduring the transition to the NEX exchange, the Company was ultimately notified\nby the BCSC that the FFCTO has been lifted; since that time, Management has\nbeen in contact with the NEX exchange and has substantially prepared its\nsubmission to resume trading on the NEX exchange. The Company expects to\nsubmit its application to resume trading within the next ten days.\n\nAlthough the regulatory hurdles are substantial, Management continues to have\na positive outlook on the Company's ability to sustain and grow revenues,\nalbeit with a cautious eye given global macroeconomic uncertainties and some\nsigns of softened general market demand, at least in the near term. As\nManagement seeks to have the Company's stock trading again, Management\ncontinues to focus on maintaining and increasing revenues, notwithstanding\npricing pressures, as well as on maintaining and improving sales volumes and\nmargins and increasing cash flows.\n\nCease-Trade Status\n\nAs noted in the Outlook section above, while the Company has been cease-traded\nsince April of 2024, the FFCTO was ultimately revoked last year. Management\nhas been in contact with the NEX exchange and is planning to submit its\napplication to the exchange to resume trading within the next ten days.\n\nSELECTED FINANCIALS\n\nAs noted above, the complete set of financial statements and management\ndiscussion and analysis for the three and six months ended June 30, 2026, are\navailable on SEDAR and on the Company's website at www.glglifetech.com.\n\nResults from Operations\n\nThe following results from operations have been derived from and should be\nread in conjunction with the Company's annual consolidated financial\nstatements for 2025 and the condensed interim consolidated financial\nstatements for the three- and six-month periods ended June 30, 2026.\n\n In thousands Canadian $, except per share amounts                             6 Months Ended June 30                        % Change            6 Months Ended June 30                         % Change          \n                                                                               2026                      2025                                    2026                       2025                                  \n Results from Continuing Operations                                                                                                                                                                               \n Revenue                                                                       $     2,333               $     2,864                (19    %)    $     4,669                $     6,030                (23    %)  \n Cost of Sales                                                                 $     (1,826  )           $     (2,433  )            25     %     $     (3,865   )           $     (5,146  )            25     %   \n % of Revenue                                                                        (78     %)                (85     %)           7      %           (83      %)                (85     %)           3      %   \n Gross Profit                                                                  $     506                 $     431                  17     %     $     804                  $     883                  (9     %)  \n % of Revenue                                                                        22      %                 15      %            7      %           17       %                 15      %            3      %   \n Expenses                                                                      $     (291    )           $     (321    )            9      %     $     (591     )           $     (618    )            4      %   \n % of Revenue                                                                        (12     %)                (11     %)           (1     %)          (13      %)                (10     %)           (3     %)  \n Income/(Loss) from Operations                                                 $     215                 $     110                  95     %     $     213                  $     265                  (20    %)  \n % of Revenue                                                                        0       %                 4       %            (4     %)          0        %                 4       %            (4     %)  \n Other Income/(Expenses)                                                       $     (6,309  )           $     23,632               (127   %)    $     (11,826  )           $     20,262               (158   %)  \n % of Revenue                                                                        (270    %)                825     %            (1096  %)          (253     %)                336     %            (589   %)  \n Net Income/(Loss)                                                             $     (6,094  )           $     23,742               (126   %)    $     (11,613  )           $     20,527               (157   %)  \n % of Revenue                                                                        (261    %)                829     %            (1090  %)          (249     %)                340     %            (589   %)  \n Net Income/(Loss) Attributable to GLG                                         $     (6,094  )           $     23,798               (126   %)    $     (11,613  )           $     20,583               (156   %)  \n % of Revenue                                                                        (261    %)                831     %            (1092  %)          (249     %)                341     %            (590   %)  \n Net Earnings/(Loss) Per Share Attributable to GLG                             $     (0.16   )           $     0.62                 (126   %)    $     (0.30    )           $     0.54                 (156   %)  \n                                                                                                                                                                                                                  \n Consolidated Results (Consolidating Continued and Discontinued Operations)                                                                                                                                       \n Net Income/(Loss) - Continuing Operations                                     $     (6,094  )           $     23,742               (126   %)    $     (11,613  )           $     20,527               (157   %)  \n Net Income/(Loss) - Discontinued Operations                                   $     0                   $     4,450                100    %     $     0                    $     3,864                (100   %)  \n Net Income/(Loss)                                                             $     (6,094  )           $     28,192               (122   %)    $     (11,613  )           $     24,391               (148   %)  \n Net Income/(Loss) Attributable to GLG                                         $     (6,094  )           $     28,196               (122   %)    $     (11,613  )           $     24,402               (148   %)  \n Net Earnings/(Loss) Per Share Attributable to GLG                             $     (0.16   )           $     0.73                 (122   %)    $     (0.30    )           $     0.64                 (148   %)  \n Other Comprehensive Income/(Loss)                                             $     (62     )           $     (74     )            16     %     $     (114     )           $     (94     )            (21    %)  \n Comprehensive Net Income/(Loss)                                               $     (6,156  )           $     28,118               (122   %)    $     (11,727  )           $     24,298               (148   %)  \n Comprehensive Net Income/(Loss) Attributable to GLG                           $     (6,156  )           $     28,120               (122   %)    $     (11,727  )           $     24,245               (148   %)  \n                                                                                                                                                                                                                  \n\nNote regarding presentation of financials:\n\nDiscontinued Operations / Restatement - Runhai\n\nIn November 2024, and as further discussed in the Company's Management\nCircular (available on the Company's website) for the Company's Annual General\nand Special Meeting, held on May 22, 2025, the Company entered into a transfer\nagreement for its Runhai subsidiary, akin to the transfer agreement discussed\nabove for Runde. Consummation of the transfer had been pending the shareholder\nvote at the Special Meeting, hence the Company reclassified Runhai's\noperations (idled since September 2023) into discontinued operations on a\nretrospective basis for years ended December 31, 2024 and 2023. With the\nshareholders having approved the consummation of the transfer agreement on May\n22, 2025, the Company recorded the disposition of Runhai and its subsidiaries\n(Bengbu) in its second quarter interim financial filings.\n\nRevenue\n\nRevenue for the three months ended June 30, 2026, decreased by 19% to $2.3\nmillion, a $0.5 million decrease compared to $2.9 million for the same period\nin 2025. This 19% decrease was primarily attributable to decreases in both\nunit prices (driven by overall market pricing pressures) and units sold for\nmany of the Company's products, relative to the comparable 2025 period.\nInternational (ex-China) sales comprised 100% of revenues in the second\nquarter (100% in second quarter of 2025).\n\nRevenue for the six months ended June 30, 2026, decreased by 23% to $4.7\nmillion, a $1.4 million decrease compared to $6.0 million for the same period\nin 2025. This 23% decrease was primarily attributable to decreases in both\nunit prices (driven by overall market pricing pressures) and units sold for\nmany of the Company's products, relative to the comparable 2025 period.\nInternational (ex-China) sales comprised 100% of revenues in the first six\nmonths of 2026 (100% in first six months of 2025).\n\nCost of Sales\n\nFor the three months ended June 30, 2026, the cost of sales decreased to $1.8\nmillion, compared to a cost of sales of $2.4 million for the same period last\nyear (a decrease in cost of sales of 25%). Cost of sales as a percentage of\nrevenues was 78% for the second quarter, a seven-percentage point improvement\ncompared to the second quarter of 2025 (85%). This seven-percentage point\nimprovement in cost of sales as a percentage of revenues is attributable to\nseveral factors, including a more favorable mix of higher margin product sales\nrelative to the second quarter of 2025, tariff rebates received in the second\nquarter of 2026, and favorable impact of foreign exchange rates relative to\nthe second quarter of 2025.\n\nFor the six months ended June 30, 2026, the cost of sales decreased to $3.9\nmillion, compared to a cost of sales of $5.1 million for the same period last\nyear (a decrease in cost of sales of 25%). Cost of sales as a percentage of\nrevenues was 83% for the first six months of 2026, a two-percentage point\nimprovement compared to the first six months of 2025 (85%).\n\nGross Profit\n\nGross profit for the three months ended June 30, 2026, increased by 17% to\n$0.5 million, compared to $0.4 million in gross profit for the same period\nlast year. This 17% increase in gross profit was driven by factors listed\nabove in the Cost of Sales section. The gross profit margin was 22% for the\nsecond quarter of 2026, compared to 15% in the second quarter of 2025, for the\nsame reasons as described above for the year-over-year comparison of cost of\nsales as a percentage of revenues.\n\nGross profit for the six months ended June 30, 2026, decreased by 9% to $0.8\nmillion, compared to $0.9 million in gross profit for the same period last\nyear. This 9% decrease in gross profit was driven primarily by the decrease in\nrevenues for the first six months of 2026 compared to the first six months of\n2025 as well as by a decrease in unit prices attributable to competitive price\npressures in the stevia marketplace. The gross profit margin was 17% for the\nfirst six months of 2026, compared to 15% for the first six months of 2025.\n\nNet Income (Loss) Attributable to the Company - Continuing Operations\n\n In thousands Canadian $                              6 Months Ended June 30                       % Change            6 Months Ended June 30                        % Change          \n                                                      2026                      2025                                   2026                       2025                                 \n Net Income/(Loss) - Continuing Operations                                                                                                                                             \n Net Income/(Loss)                                    $     (6,094  )           $     23,742              (126   %)    $     (11,613  )           $     20,527              (157   %)  \n % of Revenue                                               (261    %)                829     %           (1090  %)          (249     %)                340     %           (589   %)  \n Net Income/(Loss) Attributable to NCI                $     0                   $     (55     )           100    %     $     0                    $     (55     )           100    %   \n Net Income/(Loss) Attributable to GLG                $     (6,094  )           $     23,798              (126   %)    $     (11,613  )           $     20,583              (156   %)  \n % of Revenue                                               (261    %)                831     %           (1092  %)          (249     %)                341     %           (590   %)  \n Net Earnings/(Loss) Per Share Attributable to GLG    $     (0.16   )           $     0.62                (126   %)    $     (0.30    )           $     0.54                (156   %)  \n                                                                                                                                                                                       \n\nFor the three months ended June 30, 2026, the Company had net loss\nattributable to the Company from continuing operations of $6.1 million, an\nincrease in net loss of $29.9 million over the comparable period in 2025 (net\nincome of $28.2 million). This $29.9 million increase in net loss is\nattributable to (1) an increase in other expenses ($29.9 million) offset by\n(2) an increase in gross profit ($0.1 million).\n\nFor the six months ended June 30, 2026, the Company had net loss attributable\nto the Company from continuing operations of $11.6 million, an increase in net\nloss of $32.2 million over the comparable period in 2025 (net income of $20.6\nmillion). This $32.2 million increase in net loss is attributable to (1) an\nincrease in other expenses ($32.1 million) and (2) a decrease in gross profit\n($0.1 million).\n\nQuarterly Basic and Diluted Loss per Share\n\nThe basic loss and diluted loss per share from continuing operations was $0.16\nfor the three months ended June 30, 2026, compared with a basic and diluted\nnet income per share from continuing operations of $0.62 for the comparable\nperiod in 2025. The basic and diluted loss per share for consolidated\n(continuing) operations was $0.16 for the second quarter of 2026 compared to\nnet income per share of $0.73 for the second quarter of 2025.\n\nThe basic loss and diluted loss per share from continuing operations was $0.30\nfor the six months ended June 30, 2026, compared with a basic and diluted net\nincome per share from continuing operations of $0.54 for the comparable period\nin 2025. The basic and diluted loss per share for consolidated (continuing)\noperations was $0.30 for the first six months of 2026 compared to net income\nper share of $0.63 for the comparable period in 2025.\n\nAdditional Information\n\nAdditional information relating to the Company, including our Annual\nInformation Form, is available on SEDAR (www.sedar.com). Additional\ninformation relating to the Company is also available on our website\n(www.glglifetech.com).\n\nFor further information, please contact:\n\nSimon Springett, Investor Relations\nPhone: +1 (604) 285-2602 ext. 101\nFax: +1 (604) 285-2606\nEmail: ir@glglifetech.com\n\nAbout GLG Life Tech Corporation\n\nGLG Life Tech Corporation is a global leader in the supply of high-purity zero\ncalorie natural sweeteners including stevia and monk fruit extracts used in\nfood and beverages. Additionally, to further meet the varied needs of the food\nand beverage industry, GLG maintains its Naturals+ product line, enabling it\nto supply a host of complementary ingredients reliably sourced through its\nsupplier network in China. For further information, please visit\nwww.glglifetech.com.\n\nForward-looking statements: This press release may contain certain information\nthat may constitute \"forward-looking statements\" and \"forward looking\ninformation\" (collectively, \"forward-looking statements\") within the meaning\nof applicable securities laws. Often, but not always, forward-looking\nstatements can be identified by the use of words such as \"plans\", \"expects\" or\n\"does not expect\", \"is expected\", \"budget\", \"scheduled\", \"estimates\",\n\"forecasts\", \"intends\", \"anticipates\" or \"does not anticipate\", or \"believes\"\nor variations of such words and phrases or words and phrases that state or\nindicate that certain actions, events or results \"may\", \"could\", \"would\",\n\"might\" or \"will\" be taken, occur or be achieved.\n\nWhile the Company has based these forward-looking statements on its current\nexpectations about future events, the statements are not guarantees of the\nCompany's future performance and are subject to risks, uncertainties,\nassumptions and other factors that could cause actual results to differ\nmaterially from future results expressed or implied by such forward-looking\nstatements. Such factors include amongst others the effects of general\neconomic conditions, consumer demand for our products and new orders from our\ncustomers and distributors, changing foreign exchange rates and actions by\ngovernment authorities, uncertainties associated with legal proceedings and\nnegotiations, industry supply levels, competitive pricing pressures and\nmisjudgments in the course of preparing forward-looking statements. Specific\nreference is made to the risks set forth under the heading \"Risk Factors\" in\nthe Company's Annual Information Form for the financial year ended December\n31, 2025. In light of these factors, the forward-looking events discussed in\nthis press release might not occur.\n\nFurther, although the Company has attempted to identify factors that could\ncause actual actions, events or results to differ materially from those\ndescribed in forward-looking statements, there may be other factors that cause\nactions, events or results not to be as anticipated, estimated or intended.\nThe Company undertakes no obligation to publicly update or revise any\nforward-looking statements, whether as a result of new information, future\nevents or otherwise.\n\nAs there can be no assurance that forward-looking statements will prove to be\naccurate, as actual results and future events could differ materially from\nthose anticipated in such statements, readers should not place undue reliance\non forward-looking statements.\n\nSOURCE: GLG Life Tech Corporation\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/glg-life-tech-corporation-reports-2026-second-quarter-financial-resul-1214972)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACS2ggwha","title":"GLG Life Tech Corporation Reports 2026 Second Quarter Financial Results","author":"ACCESSWIRE","ticker":"GLGH","created":"2026-08-31T23:39:51.614Z","tickers":["GLGH"],"exchange":"","article_body":"VANCOUVER, BC / ACCESS Newswire (https://www.accessnewswire.com/) / August 31,\n2026 / GLG Life Tech Corporation (NEX:GLG.H) (\"GLG\" or the \"Company\"), a\nglobal leader in the agricultural and commercial development of high-quality\nzero-calorie natural sweeteners, announces financial results for the three and\nsix months ended June 30, 2026. The complete set of financial statements and\nmanagement discussion and analysis are available on SEDAR and on the Company's\nwebsite at www.glglifetech.com.\n\nFINANCIAL SUMMARY\n\nThe Company reported revenues of $2.3 million in the second quarter of 2026, a\ndecrease of 19% compared with $2.9 million in revenues for the second quarter\nof 2025. The Company reported gross profit for continuing operations of $0.5\nmillion for the three months ended June 30, 2026, compared to $0.4 million in\ngross profit for the same period last year. The gross profit margin was 22%\nfor the three months ended June 30, 2026, compared to 15% for the same period\nin 2025, or an increase of seven percentage points.\n\nFor the six months ended June 30, 2026, the Company reported revenues of $4.7\nmillion, a decrease of 23% compared with $6.0 million in revenues for the\ncomparable period in 2025. The Company reported gross profit for continuing\noperations of $0.8 million for the six months ended June 30, 2026, compared to\n$0.9 million in gross profit for the same period last year. The gross profit\nmargin was 17% for the six months ended June 30, 2026, compared to 15% for the\nsame period in 2025, or a decrease of two percentage points.\n\nFor the three months ended June 30, 2026, compared to the same period in 2025,\nSG&A expenses were even at $0.3 million. For the six months ended June 30,\n2026, compared to the same period in 2025, SG&A expenses were even at $0.6\nmillion.\n\nFor the three months ended June 30, 2026, the Company had net loss\nattributable to the Company from continuing operations of $6.1 million, an\nincrease in net loss of $29.9 million over the comparable period in 2025 (net\nincome of $28.2 million), when the Company recorded a substantial one-time\ngain from its disposal of its Runhai subsidiary.\n\nFor the six months ended June 30, 2026, the Company had net loss attributable\nto the Company from continuing operations of $11.6 million, an increase in net\nloss of $32.2 million over the comparable period in 2025 (net income of $20.6\nmillion).\n\nThe Company reported net loss per share from continuing operations of $0.16\nfor the second quarter 2026, a $0.78 increase in net loss per share relative\nto the second quarter of 2025 ($0.62 net income from continuing operations per\nshare). For the first six months of 2026, the Company reported net loss per\nshare from continuing operations of $0.30, an $0.84 increase in net loss per\nshare relative to the comparable period in 2025 ($0.54 net income from\ncontinuing operations per share).\n\nCORPORATE DEVELOPMENTS\n\nThe Company has held its Annual General Meeting of Shareholders on June 30,\n2026, at its Corporate Headquarters in Richmond, B.C. The shareholders voted\nin favor of all five nominated directors, with favorable votes for each\nexceeding 99%. Dr. Luke Zhang continues as Chairman of the Board and Chief\nExecutive Officer and Mr. Brian Palmieri continues as Vice Chairman of the\nBoard. Mr. David Bishop, Madame Liu Yingchun and Mr. Simon Springett continue\nas directors of the Company.\n\nCompany Outlook\n\nIn recent years, management focused particularly on mitigating the losses -\nespecially from a cash or EBITDA perspective - that the Company suffered in\nprior years and to ameliorate the Company's financial position. As a result of\nthose sustained losses, the Company has lacked the cash necessary to fully\nfund the business operations and strategic product initiatives. The Company\ncontinues to manage its cash flows carefully to mitigate risk of insolvency\nand Management's efforts have been successful in improving the Company's\nperformance, particularly its cash flows, with the Company regularly producing\npositive EBITDA. On the other hand, interest charges, most of which continue\nto be accrued rather than paid, continue to have significant impact on the\nCompany's income statement and balance sheet. As a result of these efforts, in\nrecent years and at a present, management has been successful in improving the\nCompany's cash flows compared to prior years. Nevertheless, without an\ninfusion of cash in the months ahead, the Company may not be able to realize\nits strategic plans and could eventually cease to be a going concern.\n\nA factor that has over time contributed to the Company's financial situation\nis the competitive price pressure in the stevia market over the last few years\nthat has reduced mainstream \"Reb A\" products (such as Reb A 80 and Reb A 97)\nto the lowest price levels in years; less mainstream products such as \"Reb M\"\nas well as more specialized products have also more recently been facing\nsimilarly competitive price pressure. Monk fruit prices have also become\nhighly competitive in the marketplace. To maintain margins at sustainable\nlevels, the Company has focused on managing cost of goods sold by working with\nits exclusive supplier, HHY, and continues to strive for a mix of products\nthat is weighted more heavily on higher margin, specialty products, and has\nfocused more on direct sales rather than through distributors. Margins,\nhowever, remain slimmer than desired and the impact of special tariff actions\nremains unclear.\n\nTo address operating cash requirements, management previously negotiated\nrevolving loan facilities with third parties for working capital purposes.\nManagement continues to work with third parties for its working capital needs.\nThis has been a significant departure from the Company's prior practice of\narranging loans with related parties to fund the Company's operations and the\nCompany has been successful in securing and managing these loan facilities.\n\nFurther, with an emphasis on maintaining positive cash flow, the Company has\ntaken decisive steps in the last few years to reduce its SG&A costs as well as\nreduce the cost of goods sold. In that time period, both its North American\noperations and, while extant, its Chinese operations significantly reduced\nSG&A costs. For many years, the Company's production capacity had been far\ngreater than its projected order levels, as it had then sought rapid increases\nin orders for Reb A products. Instead, a few years ago, the Company pivoted to\nfocus on \"right-sizing\" its then-extant Chinese operations - i.e., to optimize\nstaffing and production planning to meet the Company's then-projected\nproduction requirements while retaining the ability to accommodate growth in\nfuture order volumes - and management made significant progress in this area.\nThese efforts, prior to disposing of the Chinese subsidiaries, enabled the\nCompany to sell its goods at more competitive and/or more profitable prices,\nnotwithstanding the competitive price pressures arising in the market. Against\nthis historical backdrop, the Company strives to maintain product cost\nefficiencies through its production arrangement with HHY.\n\nManagement has also availed itself of opportunities to improve the Company's\nbalance sheet - to improve the Company's working capital position and to\nalleviate the debt burden that has impeded the Company's progress for many\nyears now. In 2020, management realized the sale of one of its two idle\nassets; the sale of the \"Runhao\" facility resulted in significant debt\nreduction. In 2023, the Company also realized significant debt reduction\nthrough the bankruptcy liquidation of its other long-idled asset, \"Runyang\".\nShareholders, on May 22, 2025 (and as noted further above), approved the\ntransfer of the Company's Runhai facility on terms similar to the previously\nconsummated transfer of the Company's Runde facility. The Company has thereby\nremoved Chinese bank debt from its books, with only related party debt and\nthird-party working capital loans reflected as debt on its balance sheet. The\nCompany has kept its manufacturing capabilities and practices intact through\nits contract relationship with HHY, comprised of essentially the same\npersonnel and managed under the same strict protocols as was in place with the\nCompany's Runde subsidiary, with manufacturing performed at the same Qingdao\nRunde facility.\n\nWhile revenue trends were increasing from late 2023 into early 2025,\nManagement has more recently observed indications that the growth trend -\npreviously driven both by generally increasing sales volumes from existing\ncustomers and the acquisition of new customers - is at present no longer being\nsustained. It is possible that our customers' purchasing flows are being\nimpacted by concern over global macroeconomic factors and/or in some cases (at\nleast anecdotally) reflecting weakening consumer demand across an array of end\ncustomer products (not limited to products utilizing sweeteners).\nNevertheless, Management continues to focus on ways to grow revenues - whether\nthrough innovative product offerings, new customer acquisition, ensuring\ncustomer retention, and other efforts - as Management remains driven in part,\nas a baseline goal, of ensuring EBITDA / cash flow. Management's efforts over\nthe last two years have been successful in realizing that goal and Management\naims to continue that trend.\n\nAgainst this backdrop, the Company has faced significant regulatory hurdles.\nThe Company had been cease-traded, as a result of its delay in filing its 2023\nfull-year financials (since filed, on June 28, 2024), pursuant to a British\nColumbia Securities Commission order (the failure-to-file cease trade order or\n\"FFCTO\"). As a result of that filing delay, the Company was also delayed in\nfiling its interim first quarter financials for 2024 (filed on July 23, 2024).\nFurther, the Company was under a delisting review initiated by the TSX, on the\nbasis of the Company's share price and market capitalization remaining lower\nthan the TSX's requirements, as well as the Company's sustained losses over\nthe years and negative working capital situation, that as noted above,\nculminated in a decision by the TSX to delist the Company's shares effective\nclose of business September 3, 2024.\n\nThe Company has since transferred its listing to the NEX exchange, where it is\ncurrently listed (as of September 4, 2024). While the FFCTO had been in effect\nduring the transition to the NEX exchange, the Company was ultimately notified\nby the BCSC that the FFCTO has been lifted; since that time, Management has\nbeen in contact with the NEX exchange and has substantially prepared its\nsubmission to resume trading on the NEX exchange. The Company expects to\nsubmit its application to resume trading within the next ten days.\n\nAlthough the regulatory hurdles are substantial, Management continues to have\na positive outlook on the Company's ability to sustain and grow revenues,\nalbeit with a cautious eye given global macroeconomic uncertainties and some\nsigns of softened general market demand, at least in the near term. As\nManagement seeks to have the Company's stock trading again, Management\ncontinues to focus on maintaining and increasing revenues, notwithstanding\npricing pressures, as well as on maintaining and improving sales volumes and\nmargins and increasing cash flows.\n\nCease-Trade Status\n\nAs noted in the Outlook section above, while the Company has been cease-traded\nsince April of 2024, the FFCTO was ultimately revoked last year. Management\nhas been in contact with the NEX exchange and is planning to submit its\napplication to the exchange to resume trading within the next ten days.\n\nSELECTED FINANCIALS\n\nAs noted above, the complete set of financial statements and management\ndiscussion and analysis for the three and six months ended June 30, 2026, are\navailable on SEDAR and on the Company's website at www.glglifetech.com.\n\nResults from Operations\n\nThe following results from operations have been derived from and should be\nread in conjunction with the Company's annual consolidated financial\nstatements for 2025 and the condensed interim consolidated financial\nstatements for the three- and six-month periods ended June 30, 2026.\n\n In thousands Canadian $, except per share amounts                             6 Months Ended June 30                        % Change            6 Months Ended June 30                         % Change          \n                                                                               2026                      2025                                    2026                       2025                                  \n Results from Continuing Operations                                                                                                                                                                               \n Revenue                                                                       $     2,333               $     2,864                (19    %)    $     4,669                $     6,030                (23    %)  \n Cost of Sales                                                                 $     (1,826  )           $     (2,433  )            25     %     $     (3,865   )           $     (5,146  )            25     %   \n % of Revenue                                                                        (78     %)                (85     %)           7      %           (83      %)                (85     %)           3      %   \n Gross Profit                                                                  $     506                 $     431                  17     %     $     804                  $     883                  (9     %)  \n % of Revenue                                                                        22      %                 15      %            7      %           17       %                 15      %            3      %   \n Expenses                                                                      $     (291    )           $     (321    )            9      %     $     (591     )           $     (618    )            4      %   \n % of Revenue                                                                        (12     %)                (11     %)           (1     %)          (13      %)                (10     %)           (3     %)  \n Income/(Loss) from Operations                                                 $     215                 $     110                  95     %     $     213                  $     265                  (20    %)  \n % of Revenue                                                                        0       %                 4       %            (4     %)          0        %                 4       %            (4     %)  \n Other Income/(Expenses)                                                       $     (6,309  )           $     23,632               (127   %)    $     (11,826  )           $     20,262               (158   %)  \n % of Revenue                                                                        (270    %)                825     %            (1096  %)          (253     %)                336     %            (589   %)  \n Net Income/(Loss)                                                             $     (6,094  )           $     23,742               (126   %)    $     (11,613  )           $     20,527               (157   %)  \n % of Revenue                                                                        (261    %)                829     %            (1090  %)          (249     %)                340     %            (589   %)  \n Net Income/(Loss) Attributable to GLG                                         $     (6,094  )           $     23,798               (126   %)    $     (11,613  )           $     20,583               (156   %)  \n % of Revenue                                                                        (261    %)                831     %            (1092  %)          (249     %)                341     %            (590   %)  \n Net Earnings/(Loss) Per Share Attributable to GLG                             $     (0.16   )           $     0.62                 (126   %)    $     (0.30    )           $     0.54                 (156   %)  \n                                                                                                                                                                                                                  \n Consolidated Results (Consolidating Continued and Discontinued Operations)                                                                                                                                       \n Net Income/(Loss) - Continuing Operations                                     $     (6,094  )           $     23,742               (126   %)    $     (11,613  )           $     20,527               (157   %)  \n Net Income/(Loss) - Discontinued Operations                                   $     0                   $     4,450                100    %     $     0                    $     3,864                (100   %)  \n Net Income/(Loss)                                                             $     (6,094  )           $     28,192               (122   %)    $     (11,613  )           $     24,391               (148   %)  \n Net Income/(Loss) Attributable to GLG                                         $     (6,094  )           $     28,196               (122   %)    $     (11,613  )           $     24,402               (148   %)  \n Net Earnings/(Loss) Per Share Attributable to GLG                             $     (0.16   )           $     0.73                 (122   %)    $     (0.30    )           $     0.64                 (148   %)  \n Other Comprehensive Income/(Loss)                                             $     (62     )           $     (74     )            16     %     $     (114     )           $     (94     )            (21    %)  \n Comprehensive Net Income/(Loss)                                               $     (6,156  )           $     28,118               (122   %)    $     (11,727  )           $     24,298               (148   %)  \n Comprehensive Net Income/(Loss) Attributable to GLG                           $     (6,156  )           $     28,120               (122   %)    $     (11,727  )           $     24,245               (148   %)  \n                                                                                                                                                                                                                  \n\nNote regarding presentation of financials:\n\nDiscontinued Operations / Restatement - Runhai\n\nIn November 2024, and as further discussed in the Company's Management\nCircular (available on the Company's website) for the Company's Annual General\nand Special Meeting, held on May 22, 2025, the Company entered into a transfer\nagreement for its Runhai subsidiary, akin to the transfer agreement discussed\nabove for Runde. Consummation of the transfer had been pending the shareholder\nvote at the Special Meeting, hence the Company reclassified Runhai's\noperations (idled since September 2023) into discontinued operations on a\nretrospective basis for years ended December 31, 2024 and 2023. With the\nshareholders having approved the consummation of the transfer agreement on May\n22, 2025, the Company recorded the disposition of Runhai and its subsidiaries\n(Bengbu) in its second quarter interim financial filings.\n\nRevenue\n\nRevenue for the three months ended June 30, 2026, decreased by 19% to $2.3\nmillion, a $0.5 million decrease compared to $2.9 million for the same period\nin 2025. This 19% decrease was primarily attributable to decreases in both\nunit prices (driven by overall market pricing pressures) and units sold for\nmany of the Company's products, relative to the comparable 2025 period.\nInternational (ex-China) sales comprised 100% of revenues in the second\nquarter (100% in second quarter of 2025).\n\nRevenue for the six months ended June 30, 2026, decreased by 23% to $4.7\nmillion, a $1.4 million decrease compared to $6.0 million for the same period\nin 2025. This 23% decrease was primarily attributable to decreases in both\nunit prices (driven by overall market pricing pressures) and units sold for\nmany of the Company's products, relative to the comparable 2025 period.\nInternational (ex-China) sales comprised 100% of revenues in the first six\nmonths of 2026 (100% in first six months of 2025).\n\nCost of Sales\n\nFor the three months ended June 30, 2026, the cost of sales decreased to $1.8\nmillion, compared to a cost of sales of $2.4 million for the same period last\nyear (a decrease in cost of sales of 25%). Cost of sales as a percentage of\nrevenues was 78% for the second quarter, a seven-percentage point improvement\ncompared to the second quarter of 2025 (85%). This seven-percentage point\nimprovement in cost of sales as a percentage of revenues is attributable to\nseveral factors, including a more favorable mix of higher margin product sales\nrelative to the second quarter of 2025, tariff rebates received in the second\nquarter of 2026, and favorable impact of foreign exchange rates relative to\nthe second quarter of 2025.\n\nFor the six months ended June 30, 2026, the cost of sales decreased to $3.9\nmillion, compared to a cost of sales of $5.1 million for the same period last\nyear (a decrease in cost of sales of 25%). Cost of sales as a percentage of\nrevenues was 83% for the first six months of 2026, a two-percentage point\nimprovement compared to the first six months of 2025 (85%).\n\nGross Profit\n\nGross profit for the three months ended June 30, 2026, increased by 17% to\n$0.5 million, compared to $0.4 million in gross profit for the same period\nlast year. This 17% increase in gross profit was driven by factors listed\nabove in the Cost of Sales section. The gross profit margin was 22% for the\nsecond quarter of 2026, compared to 15% in the second quarter of 2025, for the\nsame reasons as described above for the year-over-year comparison of cost of\nsales as a percentage of revenues.\n\nGross profit for the six months ended June 30, 2026, decreased by 9% to $0.8\nmillion, compared to $0.9 million in gross profit for the same period last\nyear. This 9% decrease in gross profit was driven primarily by the decrease in\nrevenues for the first six months of 2026 compared to the first six months of\n2025 as well as by a decrease in unit prices attributable to competitive price\npressures in the stevia marketplace. The gross profit margin was 17% for the\nfirst six months of 2026, compared to 15% for the first six months of 2025.\n\nNet Income (Loss) Attributable to the Company - Continuing Operations\n\n In thousands Canadian $                              6 Months Ended June 30                       % Change            6 Months Ended June 30                        % Change          \n                                                      2026                      2025                                   2026                       2025                                 \n Net Income/(Loss) - Continuing Operations                                                                                                                                             \n Net Income/(Loss)                                    $     (6,094  )           $     23,742              (126   %)    $     (11,613  )           $     20,527              (157   %)  \n % of Revenue                                               (261    %)                829     %           (1090  %)          (249     %)                340     %           (589   %)  \n Net Income/(Loss) Attributable to NCI                $     0                   $     (55     )           100    %     $     0                    $     (55     )           100    %   \n Net Income/(Loss) Attributable to GLG                $     (6,094  )           $     23,798              (126   %)    $     (11,613  )           $     20,583              (156   %)  \n % of Revenue                                               (261    %)                831     %           (1092  %)          (249     %)                341     %           (590   %)  \n Net Earnings/(Loss) Per Share Attributable to GLG    $     (0.16   )           $     0.62                (126   %)    $     (0.30    )           $     0.54                (156   %)  \n                                                                                                                                                                                       \n\nFor the three months ended June 30, 2026, the Company had net loss\nattributable to the Company from continuing operations of $6.1 million, an\nincrease in net loss of $29.9 million over the comparable period in 2025 (net\nincome of $28.2 million). This $29.9 million increase in net loss is\nattributable to (1) an increase in other expenses ($29.9 million) offset by\n(2) an increase in gross profit ($0.1 million).\n\nFor the six months ended June 30, 2026, the Company had net loss attributable\nto the Company from continuing operations of $11.6 million, an increase in net\nloss of $32.2 million over the comparable period in 2025 (net income of $20.6\nmillion). This $32.2 million increase in net loss is attributable to (1) an\nincrease in other expenses ($32.1 million) and (2) a decrease in gross profit\n($0.1 million).\n\nQuarterly Basic and Diluted Loss per Share\n\nThe basic loss and diluted loss per share from continuing operations was $0.16\nfor the three months ended June 30, 2026, compared with a basic and diluted\nnet income per share from continuing operations of $0.62 for the comparable\nperiod in 2025. The basic and diluted loss per share for consolidated\n(continuing) operations was $0.16 for the second quarter of 2026 compared to\nnet income per share of $0.73 for the second quarter of 2025.\n\nThe basic loss and diluted loss per share from continuing operations was $0.30\nfor the six months ended June 30, 2026, compared with a basic and diluted net\nincome per share from continuing operations of $0.54 for the comparable period\nin 2025. The basic and diluted loss per share for consolidated (continuing)\noperations was $0.30 for the first six months of 2026 compared to net income\nper share of $0.63 for the comparable period in 2025.\n\nAdditional Information\n\nAdditional information relating to the Company, including our Annual\nInformation Form, is available on SEDAR (www.sedar.com). Additional\ninformation relating to the Company is also available on our website\n(www.glglifetech.com).\n\nFor further information, please contact:\n\nSimon Springett, Investor Relations\nPhone: +1 (604) 285-2602 ext. 101\nFax: +1 (604) 285-2606\nEmail: ir@glglifetech.com\n\nAbout GLG Life Tech Corporation\n\nGLG Life Tech Corporation is a global leader in the supply of high-purity zero\ncalorie natural sweeteners including stevia and monk fruit extracts used in\nfood and beverages. Additionally, to further meet the varied needs of the food\nand beverage industry, GLG maintains its Naturals+ product line, enabling it\nto supply a host of complementary ingredients reliably sourced through its\nsupplier network in China. For further information, please visit\nwww.glglifetech.com.\n\nForward-looking statements: This press release may contain certain information\nthat may constitute \"forward-looking statements\" and \"forward looking\ninformation\" (collectively, \"forward-looking statements\") within the meaning\nof applicable securities laws. Often, but not always, forward-looking\nstatements can be identified by the use of words such as \"plans\", \"expects\" or\n\"does not expect\", \"is expected\", \"budget\", \"scheduled\", \"estimates\",\n\"forecasts\", \"intends\", \"anticipates\" or \"does not anticipate\", or \"believes\"\nor variations of such words and phrases or words and phrases that state or\nindicate that certain actions, events or results \"may\", \"could\", \"would\",\n\"might\" or \"will\" be taken, occur or be achieved.\n\nWhile the Company has based these forward-looking statements on its current\nexpectations about future events, the statements are not guarantees of the\nCompany's future performance and are subject to risks, uncertainties,\nassumptions and other factors that could cause actual results to differ\nmaterially from future results expressed or implied by such forward-looking\nstatements. Such factors include amongst others the effects of general\neconomic conditions, consumer demand for our products and new orders from our\ncustomers and distributors, changing foreign exchange rates and actions by\ngovernment authorities, uncertainties associated with legal proceedings and\nnegotiations, industry supply levels, competitive pricing pressures and\nmisjudgments in the course of preparing forward-looking statements. Specific\nreference is made to the risks set forth under the heading \"Risk Factors\" in\nthe Company's Annual Information Form for the financial year ended December\n31, 2025. In light of these factors, the forward-looking events discussed in\nthis press release might not occur.\n\nFurther, although the Company has attempted to identify factors that could\ncause actual actions, events or results to differ materially from those\ndescribed in forward-looking statements, there may be other factors that cause\nactions, events or results not to be as anticipated, estimated or intended.\nThe Company undertakes no obligation to publicly update or revise any\nforward-looking statements, whether as a result of new information, future\nevents or otherwise.\n\nAs there can be no assurance that forward-looking statements will prove to be\naccurate, as actual results and future events could differ materially from\nthose anticipated in such statements, readers should not place undue reliance\non forward-looking statements.\n\nSOURCE: GLG Life Tech Corporation\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/glg-life-tech-corporation-reports-2026-second-quarter-financial-resul-1214972)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-08-31T23:39:51.671604657Z","server_sent_at_ms":1788219591671},"received_at":"2026-08-31T23:39:52.037Z","source_url":"https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/glg-life-tech-corporation-reports-2026-second-quarter-financial-resul-1214972"},"analysis":{"id":"120610","press_release_id":"131702","analysis_json":{"industry":{"label":"Food Products","sector":"Consumer Staples"},"redFlags":["Going concern warning issued","Revenue declined 19% year-over-year","Delisted from TSX and transferred to NEX exchange"],"eventType":"earnings","narrative":"GLG Life Tech reported Q2 2026 revenue of $2.3 million, down 19% year-over-year, while swinging to a net loss of $6.1 million compared to prior-year net income.\n\nGross margins improved to 22% due to a favorable product mix, but the company issued a going concern warning, stating it may cease operations without a near-term cash infusion.\n\nFollowing its delisting from the TSX, the company now lists on the NEX exchange and expects to file its application to resume trading within the next ten days after the BCSC lifted a cease-trade order.","sentiment":"bearish","agentHooks":{"shouldPost":true,"suggestedAngle":"Steep revenue drop and going concern risk overshadow margin improvement."},"keyFigures":{"revenue":2333000,"revenueYoy":"-19%","customDimensions":{"net_loss":6094000,"sg_and_a":291000,"gross_profit":506000}},"quotedText":"without an infusion of cash in the months ahead, the Company may not be able to realize its strategic plans and could eventually cease to be a going concern.","namedEntities":{"people":[{"name":"Dr. Luke Zhang","role":"Chairman and CEO"},{"name":"Brian Palmieri","role":"Vice Chairman"},{"name":"David Bishop","role":"Director"},{"name":"Liu Yingchun","role":"Director"},{"name":"Simon Springett","role":"Director"}],"products":["stevia","Reb A 80","Reb A 97","Reb M","monk fruit","Naturals+"],"companies":[{"name":"GLG Life Tech Corporation","ticker":"GLGH"},{"name":"HHY","relationship":"supplier"}],"dollarAmounts":[{"amount":"$2.3 million","context":"Q2 2026 revenue"},{"amount":"$6.1 million","context":"Q2 2026 net loss"},{"amount":"$0.5 million","context":"Q2 2026 gross profit"}]},"materialImpact":{"score":4,"reasoning":"Revenue declined 19% year-over-year and the company swung to a net loss of $6.1 million. The disclosure of a going concern risk, combined with the recent delisting from the TSX to the NEX exchange, indicates significant financial distress."},"tickerRelevance":{"others":[],"primary":"GLGH"},"globalImportance":25,"audienceRelevance":15,"eventTypeSecondary":["regulatory"],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"going_concern_risk","sectorWeight":"low"}},"event_type":"earnings","event_type_secondary":["regulatory"],"sentiment":"bearish","material_impact_score":4,"narrative":"GLG Life Tech reported Q2 2026 revenue of $2.3 million, down 19% year-over-year, while swinging to a net loss of $6.1 million compared to prior-year net income.\n\nGross margins improved to 22% due to a favorable product mix, but the company issued a going concern warning, stating it may cease operations without a near-term cash infusion.\n\nFollowing its delisting from the TSX, the company now lists on the NEX exchange and expects to file its application to resume trading within the next ten days after the BCSC lifted a cease-trade order.","key_figures":{"revenue":2333000,"revenueYoy":"-19%","customDimensions":{"net_loss":6094000,"sg_and_a":291000,"gross_profit":506000}},"named_entities":{"people":[{"name":"Dr. Luke Zhang","role":"Chairman and CEO"},{"name":"Brian Palmieri","role":"Vice Chairman"},{"name":"David Bishop","role":"Director"},{"name":"Liu Yingchun","role":"Director"},{"name":"Simon Springett","role":"Director"}],"products":["stevia","Reb A 80","Reb A 97","Reb M","monk fruit","Naturals+"],"companies":[{"name":"GLG Life Tech Corporation","ticker":"GLGH"},{"name":"HHY","relationship":"supplier"}],"dollarAmounts":[{"amount":"$2.3 million","context":"Q2 2026 revenue"},{"amount":"$6.1 million","context":"Q2 2026 net loss"},{"amount":"$0.5 million","context":"Q2 2026 gross profit"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-31T23:41:24.817Z","global_importance":25,"audience_relevance":15,"importance_components":{"tickerTier":"micro-cap","eventGravity":"going_concern_risk","sectorWeight":"low"}},"durationMs":92762,"modelName":"glm-4.7"}}